Literature DB >> 22874088

Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina.

G Fabricius1, P E Bergero, M E Ormazabal, A L Maltz, D F Hozbor.   

Abstract

Due to the current epidemiological situation of pertussis, several countries have implemented vaccination strategies that include a booster dose for adolescents. Since there is still no evidence showing that the adolescent booster has a positive effect on the most vulnerable group represented by infants, it is difficult to universalize the recommendation to include such reinforcement. In this work we present an age-structured compartmental deterministic model that considers the outstanding epidemiological features of the disease in order to assess the impact of the booster dose at age 11 years (Tdap booster) to infants. To this end, we performed different parameterizations of the model that represent distinct possible epidemiological scenarios. The results obtained show that the inclusion of a single Tdap dose at age 11 years significantly reduces the incidence of the disease within this age group, but has a very low impact on the risk group (0-1 year). An effort to improve the coverage of the first dose would have a much greater impact on infants. These results hold in the 18 scenarios considered, which demonstrates the robustness of these conclusions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22874088      PMCID: PMC9151875          DOI: 10.1017/S0950268812001380

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  38 in total

1.  Opposite patterns of synchrony in sympatric disease metapopulations.

Authors:  P Rohani; D J Earn; B T Grenfell
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

2.  Pertussis vaccines: WHO position paper.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-10-01

3.  A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil.

Authors:  P M Luz; C T Codeço; G L Werneck; C J Struchiner
Journal:  Epidemiol Infect       Date:  2005-11-29       Impact factor: 2.451

4.  Stochastic fluctuations in epidemics on networks.

Authors:  M Simões; M M Telo da Gama; A Nunes
Journal:  J R Soc Interface       Date:  2008-05-06       Impact factor: 4.118

5.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-10-21       Impact factor: 17.586

6.  Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure.

Authors:  Jennie S Lavine; Aaron A King; Ottar N Bjørnstad
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

Review 7.  Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations.

Authors:  Kevin Forsyth; Masaaki Nagai; Alejandro Lepetic; Evelinda Trindade
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

8.  Transmission of Bordetella pertussis to young infants.

Authors:  Aaron M Wendelboe; Elisabeth Njamkepo; Antoine Bourillon; D Daniel Floret; Joel Gaudelus; Michael Gerber; Emmanuel Grimprel; David Greenberg; Scott Halperin; Johannes Liese; Flor Muñoz-Rivas; Remy Teyssou; Nicole Guiso; Annelies Van Rie
Journal:  Pediatr Infect Dis J       Date:  2007-04       Impact factor: 2.129

9.  Infant pertussis: who was the source?

Authors:  Kristine M Bisgard; F Brian Pascual; Kristen R Ehresmann; Claudia A Miller; Christy Cianfrini; Charles E Jennings; Catherine A Rebmann; Julie Gabel; Stephanie L Schauer; Susan M Lett
Journal:  Pediatr Infect Dis J       Date:  2004-11       Impact factor: 2.129

10.  Estimating the duration of pertussis immunity using epidemiological signatures.

Authors:  Helen J Wearing; Pejman Rohani
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

View more
  5 in total

Review 1.  Strategies and new developments to control pertussis, an actual health problem.

Authors:  María Emilia Gaillard; Daniela Bottero; Griselda Moreno; Martin Rumbo; Daniela Hozbor
Journal:  Pathog Dis       Date:  2015-08-09       Impact factor: 3.166

Review 2.  Pertussis re-emergence in the post-vaccination era.

Authors:  Elena Chiappini; Alessia Stival; Luisa Galli; Maurizio de Martino
Journal:  BMC Infect Dis       Date:  2013-03-26       Impact factor: 3.090

3.  Pertussis epidemiology in Argentina: TRENDS after the introduction of maternal immunisation.

Authors:  G Fabricius; P Martin Aispuro; P Bergero; D Bottero; M Gabrielli; D Hozbor
Journal:  Epidemiol Infect       Date:  2018-04-15       Impact factor: 4.434

4.  Evaluation of outbreak response immunization in the control of pertussis using agent-based modeling.

Authors:  Alexander Doroshenko; Weicheng Qian; Nathaniel D Osgood
Journal:  PeerJ       Date:  2016-08-18       Impact factor: 2.984

5.  Infection-acquired versus vaccine-acquired immunity in an SIRWS model.

Authors:  Tiffany Leung; Patricia T Campbell; Barry D Hughes; Federico Frascoli; James M McCaw
Journal:  Infect Dis Model       Date:  2018-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.